As shown in Table 4, the top five canonical pathways associated with Huntington’s disease, inhibition of ARE-mediated mRNA degradation, protein ubiquitination, hepatic fibrosis signaling, and glycolysis were enriched in BCO THN. Here, BCO1 is linked to Huntington disease.